Evidence map›Paper›PMID 28369767›Full record

ReviewBritish journal of pharmacology2018

Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Samantha C Salvage, Karthik H Chandrasekharan, Kamalan Jeevaratnam, Angela F Dulhunty, Andrew J Thompson, Antony P Jackson, Christopher L-H Huang

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Suicide by flecainide: a case report and review of the literature.Forensic science, medicine, and pathology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Store-Operated CaJournal of clinical medicine · 2023
    Review
  12. Cardiomyocyte electrophysiology and its modulation: current views and future prospects.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  13. Advances in basic and translational research in atrial fibrillation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  14. Feedback contributions to excitation-contraction coupling in native functioning striated muscle.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  15. FKBP12 binds to the cardiac ryanodine receptor with negative cooperativity: implications for heart muscle physiology in health and disease.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. CaJournal of translational medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Samantha C SalvageDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5793-2349
Karthik H ChandrasekharanPhysiological Laboratory, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4486-6191
Kamalan JeevaratnamFaculty of Health and Medical Sciences, University of Surrey, Guildford, UK.ORCID 0000-0002-6232-388X
Angela F DulhuntyMuscle Research Group, Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Acton, Australia.ORCID 0000-0001-9493-4944
Andrew J ThompsonDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Antony P JacksonDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2895-7387
Christopher L-H HuangDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9553-6112
University of Cambridge · GBAustralian National University · AUUniversity of Surrey · GB

Funding

British Heart Foundation PG/13/39/30293British Heart Foundation PG/14/79/31102Medical Research Council MR/M001288/1Wellcome TrustWellcome Trust 105727/Z/14/Z
6 · The paper itself

Abstract

Flecainide suppresses cardiac tachyarrhythmias including paroxysmal atrial fibrillation, supraventricular tachycardia and arrhythmic long QT syndromes (LQTS), as well as the Ca LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

Indexed as

AnimalsAnti-Arrhythmia AgentsArrhythmias, CardiacCalciumFlecainideHumansPotassium Channel BlockersPotassium ChannelsRyanodine Receptor Calcium Release ChannelAnti-Arrhythmia AgentsCalciumFlecainidePotassium Channel BlockersPotassium ChannelsRyanodine Receptor Calcium Release Channel

Identifiers

PMID28369767
PMCPMC5866987
OpenAlexW2604221121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.